These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7214106)

  • 61. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radioimmunoassay of haloperidol in human serum: correlation of serum haloperidol with serum prolactin.
    Poland RE; Rubin RT
    Life Sci; 1981 Nov; 29(18):1837-45. PubMed ID: 7311717
    [No Abstract]   [Full Text] [Related]  

  • 63. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
    Liu KL; Lung FW
    Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prolactin response in tardive dyskinesia.
    Wolf ME; Bowie L; Keener S; Mosnaim AD
    Biol Psychiatry; 1982 Apr; 17(4):485-90. PubMed ID: 7082714
    [No Abstract]   [Full Text] [Related]  

  • 66. [Influence of extrapyramidal disorders induced by haloperidol on phenamine stereotypy and the effects of schizophrenic patients' serum (experimental study)].
    Bobritskaia ZM; Gorbatko LG; Litvinova NM; Stoliarov GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(4):591-5. PubMed ID: 559400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR; Hollister LE; Arnold KV; Earle GM
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
    Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
    Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
    [No Abstract]   [Full Text] [Related]  

  • 69. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
    Garver DL; Hirschowitz J; Glicksteen GA; Kanter DR; Mavroidis ML
    J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
    Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A multicentre study on the efficacy and safety of individualized dosage of haloperidol (Haldol) in refractory chronic psychotics.
    Nicodeme A; Vranckx-Haenen J; Wouters J
    Acta Psychiatr Belg; 1977; 77(4):516-29. PubMed ID: 337756
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Haloperidol plasma level monitoring in neuropsychiatric patients.
    Morselli PL; Bianchetti G; Dugas M
    Ther Drug Monit; 1982; 4(1):51-8. PubMed ID: 7041338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The characteristics of side-effects of bromperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Ishida M; Tanaka O; Mihara K; Kaneko S; Otani K
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):103-6. PubMed ID: 11929578
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.
    Kane JM; Crandall DT; Marcus RN; Eudicone J; Pikalov A; Carson WH; Swyzen W
    Schizophr Res; 2007 Sep; 95(1-3):143-50. PubMed ID: 17644313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics of haloperidol decanoate. A 2-year follow-up.
    Reyntigens AJ; Heykants JJ; Woestenborghs RJ; Gelders YG; Aerts TJ
    Int Pharmacopsychiatry; 1982; 17(4):238-46. PubMed ID: 7185768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Haloperidol blood levels during dosage reduction in chronic schizophrenic patients.
    Goldman Z; Ebstein RP; Lerer B; Zohar J; Hermoni M; Belmaker RH
    Neuropsychobiology; 1981; 7(6):281-4. PubMed ID: 7312145
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model".
    Langer G; Pühringer W
    Acta Psychiatr Belg; 1980; 80(5):574-83. PubMed ID: 7234451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.